Statin Use and Survival in Early Breast Cancer According to Different Intrinsic Subtypes - Top-Institutions - MDSpire

Statin Use and Survival in Early Breast Cancer According to Different Intrinsic Subtypes

  • By

  • Santeri Palmi

  • Otso Arponen

  • Mika Murto

  • Aino Siltari

  • Arja Jukkola

  • Teemu Murtola

  • June 2, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Turku University Hospital
    Turku University Hospital

    Turku, Finland

    Key Differentiators

    • Oncology

  • #2

    Tampere University Hospital
    Tampere University Hospital

    Tampere, Finland

    Key Differentiators

    • Oncology

  • #3

    The Finnish Cancer Registry
    The Finnish Cancer Registry

    Helsinki, Finland

    Key Differentiators

    • Cancer Registry

  • #4

    Institute for Health and Welfare (THL)
    Institute for Health and Welfare (THL)

    Helsinki, Finland

    Key Differentiators

    • Public Health

Original Source(s)

Statin Use and Survival in Early Breast Cancer According to Different Intrinsic Subtypes

  • by Santeri Palmi, Otso Arponen, Mika Murto, Aino Siltari, Arja Jukkola, Teemu Murtola

  • June 2, 2026

Related Content

Insulin-like growth factor 1 receptor regulates breast cancer cell adhesion through beta-1 integrin

New Mammography Screening Guidance: Clinical Considerations for Risk-Based Care

New guidance from the American College of Physicians (ACP) recommends biennial mammography screening for average-risk women ages 50 to 74.

  • by

  • May 26, 2026

  • 5 min
25HC regulates the polarization of CD163+ macrophages in the immune microenvironment of triple-negative breast cancer through the interferon pathway